These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35945389)

  • 1. Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3 cm or larger: a prospective study.
    Gobara H; Matsui Y; Uka M; Tomita K; Umakoshi N; Araki M; Sakurai J; Iguchi T; Hiraki T
    Int J Clin Oncol; 2022 Oct; 27(10):1589-1595. PubMed ID: 35945389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study.
    Umakoshi N; Iguchi T; Matsui Y; Tomita K; Uka M; Kawabata T; Munetomo K; Nagata S; Gobara H; Araki M; Hiraki T
    Jpn J Radiol; 2023 Sep; 41(9):1007-1014. PubMed ID: 37002430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Arterial Embolization with a Mixture of Absolute Ethanol and Iodized Oil for Poorly Visualized Endophytic Renal Masses Prior to CT-Guided Percutaneous Cryoablation.
    Michimoto K; Shimizu K; Kameoka Y; Sadaoka S; Miki J; Kishimoto K
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1589-1594. PubMed ID: 27380871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study.
    Gobara H; Hiraki T; Iguchi T; Matsui Y; Sakurai J; Uka M; Tomita K; Komaki T; Kobayasi Y; Araki M; Watanabe T; Kanazawa S
    Int J Clin Oncol; 2021 Mar; 26(3):562-568. PubMed ID: 33174078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan.
    Uka M; Iguchi T; Okawa N; Matsui Y; Tomita K; Umakoshi N; Munetomo K; Gobara H; Araki M; Hiraki T
    Jpn J Radiol; 2022 Nov; 40(11):1201-1209. PubMed ID: 35727459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of iodized oil embolization on temperature change during cryoablation for renal cell carcinoma.
    Chang NW; Liu CA; Hong JA; Shen SH
    Minim Invasive Ther Allied Technol; 2024 Aug; 33(4):237-244. PubMed ID: 38491916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial embolization of T1b and T2a renal cell carcinoma prior to percutaneous cryoablation: a retrospective comparative study.
    Salei A; Raymond M; Savage C; Huang J; Caridi TM; Rais-Bahrami S; Gunn AJ
    Abdom Radiol (NY); 2023 Feb; 48(2):773-779. PubMed ID: 36454278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
    Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
    J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
    Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
    Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
    Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
    Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of CT-guided cryoablation after lipiodol marking and embolization for RCC.
    Kajiwara K; Yoshimatsu R; Komoto M; Maeda H; Yamanishi T; Minamiguchi H; Karashima T; Inoue K; Awai K; Yamagami T
    Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):923-929. PubMed ID: 35057706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study.
    Georgiades CS; Rodriguez R
    Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1494-9. PubMed ID: 24385225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
    Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
    AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease.
    Gobara H; Nakatsuka A; Shimizu K; Yamanaka T; Matsui Y; Iguchi T; Hiraki T; Yamakado K
    Jpn J Radiol; 2019 Jun; 37(6):481-486. PubMed ID: 30941617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
    Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
    Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.